Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lindås

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|September 24, 2005
Serum levels of angioregulatory mediators in healthy individuals depend on age and physical activity: studies of angiogenin, basic fibroblast growth factor, leptin and endostatinO Bruserud, F Grovan, R Lindås, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 10, 1991
[Physicians' work load. A comparison between company physicians and general practitioners in private practice]R Lindås, T Holst-Larsen, P O Johansen, et al.
Bone Marrow Transplantation|June 30, 2015
Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trialP Gimsing, Ø Hjertner, N Abildgaard, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Clinical and Laboratory Investigation|September 24, 2005
Serum levels of angioregulatory mediators in healthy individuals depend on age and physical activity: studies of angiogenin, basic fibroblast growth factor, leptin and endostatinO Bruserud, F Grovan, R Lindås, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 10, 1991
[Physicians' work load. A comparison between company physicians and general practitioners in private practice]R Lindås, T Holst-Larsen, P O Johansen, et al.
Bone Marrow Transplantation|June 30, 2015
Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trialP Gimsing, Ø Hjertner, N Abildgaard, et al.
Pageof 1